# Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/anaemia-and-resistance-to-erythropoiesis-stimulating-agents-as-prognostic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Vincenzo Panichi,Alberto Rosati,Roberto Bigazzi,Sabrina Paoletti,Elide Mantuano,S. Beati,Veronica Marchetti,G. Bernabini,Giovanni Grazi,Giovanni Manca Rizza,M. Migliori,Robert Giusti,A. Lippi,A. Casani,Giovanni Barsotti,Ciro Tetta,on behalf of the RISCAVID Study Group |
| Citations | 155 |
| DOI | 10.1093/ndt/gfq802 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2097586983 |
| PMID | 21325348 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Roberto Bigazzi](https://scholariq.org/researchers/roberto-bigazzi/)

## Paper journal

- [Nephrology Dialysis Transplantation](https://scholariq.org/journals/nephrology-dialysis-transplantation/)

## Paper primary topic

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)

## Paper topics

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Adipokines, Inflammation, and Metabolic Diseases](https://scholariq.org/topics/adipokines-inflammation-and-metabolic-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.